Pharmacological strategies to overcome immune checkpoint inhibitor resistance in non-small cell lung cancer.
Saved in:
| Title: | Pharmacological strategies to overcome immune checkpoint inhibitor resistance in non-small cell lung cancer. |
|---|---|
| Authors: | Xu Y; Department of Oncology, Zhenjiang First People's Hospital, Zhenjiang, China., Shen H; Department of Oncology, Zhenjiang First People's Hospital, Zhenjiang, China., Shang D; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Zhu C; Department of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Jan 08; Vol. 15, pp. 1665239. Date of Electronic Publication: 2026 Jan 08 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1665239 |
